Clinical trial
Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF Patients - "ACT - C ACLF Study
NCT06298656 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute hemodynamiC Response To Carvedilol Predicts Survival in ACLF Patients - "ACT - C ACLF Study
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 10, 2024
- Completion date
- February 28, 2026
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.